info@allievapharma.com

  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company
OUR CATALOGUE OUR CATALOGUE

    • All Products

    OUR PRODUCTS

    Allieva Pharma offers a wide range of pharmaceutical products including tablets, capsules, and injections. Our products are manufactured with high-quality standards and trusted across India and international markets.

    LENALIEVA 10MG Lenalidomide Capsules 10mg by Allieva Pharma Private Limited

    LENALIEVA 10MG

    Lenalidomide Capsules 10mg

    LENALIEVA 10 mg contains Lenalidomide, an immunomodulatory anticancer drug (IMiD). It enhances immune response, inhibits tumor cell proliferation, reduces angiogenesis, and induces apoptosis of malignant cells. It is a more potent and safer analogue of thalidomide.

    View Details
    LENALIEVA 5MG Lenalidomide Capsules 5mg by Allieva Pharma Private Limited

    LENALIEVA 5MG

    Lenalidomide Capsules 5mg

    LENALIEVA 5 mg contains Lenalidomide, an immunomodulatory and anticancer medicine (IMiD). It works by modulating the immune system, inhibiting tumor cell growth, reducing angiogenesis, and inducing cancer cell apoptosis. Lenalidomide is a thalidomide analogue with improved efficacy and safety.

    View Details
    SUNITCAP 50MG Sunitinib Malate Capsules 50mg by Allieva Pharma Private Limited

    SUNITCAP 50MG

    Sunitinib Malate Capsules 50mg

    SUNITCAP 50 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that blocks receptors involved in tumor growth, angiogenesis (blood vessel formation), and cancer cell survival, thereby slowing cancer progression.

    View Details
    SUNITCAP 25MG Sunitinib Malate Capsules 25mg by Allieva Pharma Private Limited

    SUNITCAP 25MG

    Sunitinib Malate Capsules 25mg

    SUNITCAP 25 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that inhibits receptors involved in tumor growth, angiogenesis, and cancer cell survival, thereby slowing disease progression.

    View Details
    SUNITCAP 12.5MG Sunitinib Malate Capsules 12.5mg by Allieva Pharma Private Limited

    SUNITCAP 12.5MG

    Sunitinib Malate Capsules 12.5mg

    SUNITCAP 12.5 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that blocks receptors involved in tumor growth, angiogenesis (blood vessel formation), and cancer cell survival, thereby slowing disease progression.

    View Details
    ALIMLIEVA 500MG Pemetrexed Injection IP 500mg by Allieva Pharma Private Limited

    ALIMLIEVA 500MG

    Pemetrexed Injection IP 500mg

    ALIMLIEVA 500 mg contains Pemetrexed, a chemotherapy (anticancer) drug classified as a multitargeted antifolate antimetabolite. It inhibits key enzymes involved in purine and pyrimidine synthesis, leading to inhibition of DNA and RNA synthesis and cancer cell death. It is mainly used in non-squamous lung cancers.

    View Details
    ALIMLIEVA 100MG Pemetrexed Injection IP 100mg by Allieva Pharma Private Limited

    ALIMLIEVA 100MG

    Pemetrexed Injection IP 100mg

    ALIMLIEVA 100 mg contains Pemetrexed, a chemotherapy (anticancer) medicine classified as a multitargeted antifolate. It inhibits several enzymes involved in DNA and RNA synthesis, leading to suppression of cancer cell growth. It is mainly used in non-squamous lung cancers.

    View Details
    OXALIEVA 100MG Oxaliplatin Injection USP 100mg by Allieva Pharma Private Limited

    OXALIEVA 100MG

    Oxaliplatin Injection USP 100mg

    OXALIEVA 100 mg contains Oxaliplatin, a third-generation platinum-based chemotherapy (anticancer) drug. It forms DNA cross-links, inhibiting DNA synthesis and transcription, which leads to cancer cell death. Oxaliplatin is particularly effective in colorectal cancer and has lower nephrotoxicity and ototoxicity compared to cisplatin.

    View Details
    OXALIEVA 50MG Oxaliplatin Injection USP 50mg by Allieva Pharma Private Limited

    OXALIEVA 50MG

    Oxaliplatin Injection USP 50mg

    OXALIEVA 50 mg contains Oxaliplatin, a third-generation platinum-based chemotherapy (anticancer) drug. It works by forming DNA cross-links, which inhibit DNA synthesis and transcription, leading to cancer cell death. Oxaliplatin is especially effective in colorectal cancer and has less kidney and hearing toxicity than cisplatin.

    View Details
    CISLIEVA 50MG Cisplatin Injection IP 50mg by Allieva Pharma Private Limited

    CISLIEVA 50MG

    Cisplatin Injection IP 50mg

    CISLIEVA 50 mg contains Cisplatin, a platinum-based chemotherapy (anticancer) medicine. It works by forming DNA cross-links, which inhibit DNA replication and transcription, leading to death of rapidly dividing cancer cells. Cisplatin is widely used in many solid tumors.

    View Details
    CISLIEVA 10MG Cisplatin Injection IP 10 MG by Allieva Pharma Private Limited

    CISLIEVA 10MG

    Cisplatin Injection IP 10 MG

    CISLIEVA 10 mg contains Cisplatin, a platinum-based chemotherapy (anticancer) drug. It works by forming DNA cross-links, which inhibit DNA synthesis and repair, leading to death of rapidly dividing cancer cells. Cisplatin is a cornerstone drug in many solid tumor chemotherapy regimens.

    View Details
    CARBOLIEVA 450MG Carboplatin Injection IP 450mg by Allieva Pharma Private Limited

    CARBOLIEVA 450MG

    Carboplatin Injection IP 450mg

    CARBOLIEVA 450 mg contains Carboplatin, a platinum-based chemotherapy (anticancer) medicine. It acts by forming DNA cross-links, which inhibit DNA synthesis and repair, leading to death of rapidly dividing cancer cells. Compared to cisplatin, carboplatin generally causes less kidney and nerve toxicity.

    View Details

    24/7 Clients Support

    Best Price

    Quality Assurance